HIGHLIGHTS
- who: Surbhi Jain and collaborators from the Department of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India have published the Article: Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates, in the Journal: Pharmaceutics 2022, 14, 1590. of /2022/
- what: The present review discusses various metabolic pathways of the Leishmania parasite and some targeting these pathways effectively that could be drugs against leishmaniasis in the future.
- how: The design and manufacture of a library of pyrazolo pyrimidine nucleosides were disclosed and their action against T . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.